Rafferty Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q3
– Sell
-173,700
Closed -$5.77M – 201
2013
Q2
$5.77M Buy
+173,700
New +$5.77M 0.79% 24

Other funds holding IHE

Rafferty Asset Management's IHE Position: Q3 2013 in Review

Rafferty Asset Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2013, closing a stake of 173,700 shares — an estimated $5.77M sold.

Rafferty Asset Management first reported a position in IHE in Q2 2013 and held it in 1 quarter. The position peaked at $5.77M in Q2 2013. 63 funds tracked by Wall St. Rank hold IHE as of Q3 2013.

  • Rafferty Asset Management reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2013 after selling out during the quarter.
  • Rafferty Asset Management sold 173,700 iShares US Pharmaceuticals ETF shares in Q3 2013, an estimated $5.77M.
  • Rafferty Asset Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 1 quarter.
  • Rafferty Asset Management's iShares US Pharmaceuticals ETF position peaked at $5.77M in Q2 2013.
  • 63 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2013.

Based on Rafferty Asset Management's 13F filing for Q3 2013, filed 8 Nov 2013.